Renzo Wolbold

2.1k total citations · 1 hit paper
9 papers, 1.8k citations indexed

About

Renzo Wolbold is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Renzo Wolbold has authored 9 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Oncology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Renzo Wolbold's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Renzo Wolbold is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Renzo Wolbold collaborates with scholars based in Germany, Australia and United States. Renzo Wolbold's co-authors include P. Neuhaus, Ulrich M. Zanger, Oliver Burk, Kathrin Klein, Michel Eichelbaum, Elisabeth Hustert, Leszek Wojnowski, Andreas K. Nüssler, Jürgen Brockmöller and Matthias Schwab and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and British Journal of Clinical Pharmacology.

In The Last Decade

Renzo Wolbold

9 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The genetic determinants of the CYP3A5 polymorphism

2001 560 citations Elisabeth Hustert, Michael Haberl et al. Pharmacogenetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renzo Wolbold Germany	8	1.2k	763	433	274	248	9	1.8k
Peter Kuehl United States	6	1.3k 1.1×	1.0k 1.3×	613 1.4×	487 1.8×	420 1.7×	8	2.4k
Vishal Lamba United States	20	1.0k 0.9×	831 1.1×	431 1.0×	531 1.9×	332 1.3×	30	2.2k
Paul B. Watkins United States	15	956 0.8×	1.0k 1.3×	531 1.2×	227 0.8×	207 0.8×	20	1.7k
Darlene Barr United States	16	644 0.6×	547 0.7×	263 0.6×	300 1.1×	169 0.7×	33	1.6k
Cynthia Brimer United States	9	1.7k 1.5×	1.5k 1.9×	827 1.9×	581 2.1×	427 1.7×	9	3.0k
Mahfoud Assem United States	22	1.5k 1.3×	1.4k 1.8×	722 1.7×	851 3.1×	399 1.6×	33	3.2k
Patrick Caron Canada	30	595 0.5×	770 1.0×	312 0.7×	778 2.8×	144 0.6×	80	2.4k
Barry P. King United Kingdom	9	1.1k 1.0×	321 0.4×	269 0.6×	163 0.6×	195 0.8×	9	1.5k
JJ Swen Netherlands	8	917 0.8×	243 0.3×	593 1.4×	193 0.7×	344 1.4×	10	1.4k
Jean Combalbert France	12	579 0.5×	316 0.4×	182 0.4×	201 0.7×	74 0.3×	14	1.8k

Countries citing papers authored by Renzo Wolbold

Since Specialization

Citations

This map shows the geographic impact of Renzo Wolbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renzo Wolbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renzo Wolbold more than expected).

Fields of papers citing papers by Renzo Wolbold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renzo Wolbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renzo Wolbold. The network helps show where Renzo Wolbold may publish in the future.

Co-authorship network of co-authors of Renzo Wolbold

This figure shows the co-authorship network connecting the top 25 collaborators of Renzo Wolbold. A scholar is included among the top collaborators of Renzo Wolbold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renzo Wolbold. Renzo Wolbold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Oscarson, Mikael, Oliver Burk, Stefan Winter, et al.. (2007). Effects of rifampicin on global gene expression in human small intestine. Pharmacogenetics and Genomics. 17(11). 907–918. 22 indexed citations

2.

Coller, Janet K., Kathrin Klein, Renzo Wolbold, et al.. (2003). Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity. British Journal of Clinical Pharmacology. 57(1). 105–111. 23 indexed citations

3.

Wolbold, Renzo. (2003). Sex is a major determinant of CYP3A4 expression in human liver. Hepatology. 38(4). 978–988. 205 indexed citations

4.

Wolbold, Renzo, Kathrin Klein, Oliver Burk, et al.. (2003). Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver. Hepatology. 38(4). 978–988. 420 indexed citations

5.

Burk, Oliver, Heike Tegude, Ina Koch, et al.. (2002). Molecular Mechanisms of Polymorphic CYP3A7 Expression in Adult Human Liver and Intestine. Journal of Biological Chemistry. 277(27). 24280–24288. 156 indexed citations

6.

Coller, Janet K., Kathrin Klein, Renzo Wolbold, et al.. (2002). The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z‐4‐hydroxy‐tamoxifen in human liver. British Journal of Clinical Pharmacology. 54(2). 157–167. 106 indexed citations

7.

Koch, Ina, Renzo Wolbold, Jürgen Brockmöller, et al.. (2002). Interindividual Variability and Tissue-Specificity in the Expression of Cytochrome P450 3A mRNA. Drug Metabolism and Disposition. 30(10). 1108–1114. 262 indexed citations

8.

Glaeser, Hartmut, Siegfried Drescher, Oliver Burk, et al.. (2001). Induction of CYP2C8, CYP2C9, and CYP3A4 by rifampin in shedded human enterocytes.. Drug Metabolism Reviews. 33. 90. 1 indexed citations

9.

Hustert, Elisabeth, Michael Haberl, Oliver Burk, et al.. (2001). The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics. 11(9). 773–779. 560 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact